Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul;52(3):375-381.
doi: 10.1177/00494755221076896. Epub 2022 Mar 18.

Clinical Profile and Outcomes of Diabetic Ketoacidosis during the COVID-19 Pandemic in North India

Ravindran Kiran  1 , Atul Saroch  1 , Ashok Kumar Pannu  1 , Navneet Sharma  1 , Pinaki Dutta  2 , Mohan Kumar  1
Affiliations

Clinical Profile and Outcomes of Diabetic Ketoacidosis during the COVID-19 Pandemic in North India

Ravindran Kiran et al. Trop Doct. 2022 Jul.

Abstract

Although recent data have shown a declining trend in mortality in diabetic ketoacidosis (DKA), the outcomes are likely to be different during the coronavirus (COVID-19) pandemic. We conducted a prospective cohort study to evaluate the spectrum and outcomes of adult DKA during the pandemic and document differences in DKA patients with or without COVID-19. A total of 169 patients (mean age 44 years) were admitted at the Emergency Department of PGIMER, Chandigarh (India), from January 2020 to June 2021. The precipitating factors were noncompliance with antidiabetic therapy (77.5%), infections (62.7%), and noninfectious conditions (21.3%). Thirty-nine (23.1%) patients had COVID-19, including 31 with severe infection. DKA severity and resolution, ventilator requirement, hospital stay, and mortality were similar in the patients with or without COVID-19. In-hospital mortality was 39.6% (n = 67). The independent mortality predictors were ventilator requirement (p-0.000), an infection trigger (p-0.049), and hyperosmolarity (p-0.048). DKA mortality is increased significantly during the pandemic.

Keywords: COVID-19; coronavirus disease 2019; diabetic ketoacidosis; mortality; noncompliance; predisposition.

PubMed Disclaimer

References

    1. Global report on diabetes. Geneva: World Health Organization; 2016. Available at: https://www.who.int/publications/i/item/9789241565257. Accessed May 3, 2021.
    1. Singh H, Saroch A, Pannu AKet al.et al.Clinical and biochemical profile, precipitants and prognostic factors of diabetic ketoacidosis: a retrospective study from a tertiary care center of north India. Diabetes Metab Syndr 2019;13:2357–2360. - PubMed
    1. Kitabchi AE, Umpierrez GE, Fisher JNet al.et al.Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab 2008;93:1541–1552. - PMC - PubMed
    1. Fayfman M, Pasquel FJ, Umpierrez GE. Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am 2017;101:587–606. - PMC - PubMed
    1. Kitabchi AE, Umpierrez GE, Miles JM, et al.Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009;32:1335–1343. - PMC - PubMed